Table 1.
Baseline characteristics of malnourished cancer patients.
| Overall | Female | Male | |
|---|---|---|---|
| n | 628 | 260 | 368 |
| Sociodemographic | |||
| Age (years), mean (SD) | 72.0 (12.5) | 72.3 (11.5) | 71.9 (13.2) |
| Nutritional status | |||
| BMI (kg/m2), mean (SD) | 24.6 (4.8) | 24.6 (5.4) | 24.6 (4.3) |
| Weight (kg), mean (SD) | 70.7 (14.9) | 65.3 (14.0) | 74.4 (14.5) |
| Height (cm), mean (SD) | 168.6 (8.8) | 162.2 (6.5) | 173.1 (7.2) |
| NRS 3 | 175 (27.9%) | 72 (27.7%) | 103 (28.0%) |
| NRS 4 | 200 (31.8%) | 85 (32.7%) | 115 (31.3%) |
| NRS 5 | 253 (40.3%) | 103 (39.6%) | 150 (40.8%) |
| Main diagnosis | |||
| Cancer | 319 (50.8%) | 141 (54.2%) | 178 (48.4%) |
| Infection | 132 (21.0%) | 44 (16.9%) | 88 (23.9%) |
| Cardiovascular | 34 (5.4%) | 16 (6.2%) | 18 (4.9%) |
| Frailty | 45 (7.2%) | 21 (8.1%) | 24 (6.5%) |
| Lung | 22 (3.5%) | 7 (2.7%) | 15 (4.1%) |
| Gastrointestinal | 29 (4.6%) | 15 (5.8%) | 14 (3.8%) |
| Neurological/psychiatric | 13 (2.1%) | 5 (1.9%) | 8 (2.2%) |
| Renal | 11 (1.8%) | 3 (1.2%) | 8 (2.2%) |
| Metabolic | 6 (1.0%) | 3 (1.2%) | 3 (0.8%) |
| Other | 12 (1.9%) | 4 (1.5%) | 8 (2.2%) |
| Comorbidities | |||
| Tumor | 580 (92.4%) | 237 (91.2%) | 343 (93.2%) |
| Hypertension | 313 (49.8%) | 137 (52.7%) | 176 (47.8%) |
| Chronic kidney disease (without kidney replacement therapy) | 190 (30.3%) | 71 (27.3%) | 119 (32.3%) |
| Coronary heart disease | 156 (24.8%) | 47 (18.1%) | 109 (29.6%) |
| Diabetes mellitus | 125 (19.9%) | 49 (18.8%) | 76 (20.7%) |
| Chronic heart failure | 73 (11.6%) | 23 (8.8%) | 50 (13.6%) |
| Chronic obstructive pneumopathypulmonary disease | 70 (11.1%) | 24 (9.2%) | 46 (12.5%) |
| Peripheral arterial vascular disease | 43 (6.8%) | 13 (5.0%) | 30 (8.2%) |
| Stroke | 39 (6.2%) | 10 (3.8%) | 29 (7.9%) |
| Dementia | 14 (2.2%) | 6 (2.3%) | 8 (2.2%) |
| Tumor entity | |||
| Hematological tumors | 124 (19.7%) | 53 (20.4%) | 71 (19.3%) |
| Lung cancer | 103 (16.4%) | 29 (11.2%) | 74 (20.1%) |
| Gastrointestinal tumors | 78 (12.4%) | 30 (11.5%) | 48 (13.0%) |
| Prostate carcinoma | 62 (9.9%) | 62 (16.8%) | |
| Breast carcinoma | 56 (8.9%) | 55 (21.2%) | 1 (0.3%) |
| Other * | 205 (32.6%) | 93 (35.8%) | 112 (30.4%) |
| Handgrip strength (kg), mean (SD) | |||
| Overall HGS | 23.6 (10.7) | 17.3 (6.3) | 28.0 (10.8) |
* Gynecological cancers, kidney and urothelial cancers, ear, nose and throat carcinoma, genital cancer, skin cancer, pleural mesothelioma and cancer of unknown primary.